Conatus Pharmaceuticals Inc. Business Operations Contracts & Agreements
14 Contracts & Agreements
- Collaboration Agreements (1 contract)
- Development Agreements (1)
- Distribution Agreements (1)
- Indemnification Agreements (2)
- Sales Agreements (2)
- Supply Agreements (1)
- Termination Agreements (6)
- Notice of Termination and Letter Agreement, dated September 18, 2023, by and between the Company and Joyce Reyes (Filed With SEC on November 9, 2023)
- Notice of Termination and Letter Agreement, dated September 18, 2023, by and between the Company and Alfred P. Spada (Filed With SEC on November 9, 2023)
- Notice of Termination and Letter Agreement, dated September 18, 2023 by and between the Company and Steven J. Mento (Filed With SEC on November 9, 2023)
- Letter Agreement by and between Histogen, Inc. and Allergan Sales, LLC, dated March 18, 2022 (Filed With SEC on March 22, 2022)
- Collaborative Development and Commercialization Agreement, dated as of October 26, 2020, by and between the Company and Amerimmune LLC (Filed With SEC on October 27, 2020)
- Amended and Restated Supply Agreement, dated December 16, 2013, by and between Histogen Inc. and Suneva Medical, Inc (Filed With SEC on February 7, 2020)
- Termination of Stockholder Agreements, dated January 28, 2020, by and among Histogen Inc., Lordship Ventures Histogen Holdings LLC, Pineworld Capital Limited, Gail K. Naughton,... (Filed With SEC on February 7, 2020)
- Conversion, Termination and Release Agreement, dated August 10, 2016, by and among Histogen Inc., Jonathan Jackson, Lordship Ventures LLC and Lordship Ventures Histogen Holdings... (Filed With SEC on February 7, 2020)
- Settlement, Release and Termination Agreement, dated April 5, 2019, by and among Histogen Inc., PUR Biologics, LLC, Wylde, LLC, Christopher Wiggins and Ryan Fernan (Filed With SEC on February 7, 2020)
- Form of Indemnification Agreement, between Histogen Inc. and its officers and directors (Filed With SEC on February 7, 2020)
- Amendment to Option, Collaboration and License Agreement, dated September 30, 2019, by and between Novartis Pharma AG and Conatus (Filed With SEC on October 4, 2019)
- At Market Issuance Sales Agreement, dated August 2, 2018, between the Registrant and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on August 2, 2018)
- FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on July 1, 2013)
- DISTRIBUTION AGREEMENT FOR EMRICASAN ASSETS by and between CONATUS PHARMACEUTICALS INC. and IDUN PHARMACEUTICALS, INC. January 10, 2013 DISTRIBUTION AGREEMENT (Filed With SEC on June 14, 2013)
